Chromadex Corp.(NASDAQ : CDXC)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Process Industries » Chemicals Specialty
|APD||Air Products & Chemicals, Inc.||1.66%||292.76||1.5%||$323.69m|
|LYB||LyondellBasell Industries NV||0.83%||99.15||2.8%||$183.90m|
|DQ||Daqo New Energy Corp.||0.85%||64.04||0.0%||$105.68m|
|REGI||Renewable Energy Group, Inc.||-2.34%||53.00||19.6%||$49.04m|
|ASH||Ashland Global Holdings, Inc.||-0.13%||95.74||3.3%||$45.98m|
|TROX||Tronox Holdings Plc||0.40%||25.30||3.0%||$41.83m|
Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The companyâ€™s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firmâ€™s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.